ENVISIA THERAPEUTICS TO PRESENT NEW DATA ON LEAD PROGRAMS AT ASCRS 2017 ANNUAL MEETING
Company to Deliver Key Data Presentations at the Pre-Eminent Meeting for Ophthalmologists Specializing in Anterior Segment
RESEARCH TRIANGLE PARK, NC – May 3, 2017 – Envisia Therapeutics today announced that the Company will present new data for its next generation product candidates, ENV515 for glaucoma and ENV1105 for diabetic macular edema, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium and Congress being held May 5-9, 2017 in Los Angeles, CA. ASCRS is the largest US meeting dedicated exclusively to the needs of the anterior segment specialist. Read more here.